🇺🇸 nicotine nasal spray in United States

21 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Incorrect Drug Administration Duration — 6 reports (28.57%)
  2. Dependence — 5 reports (23.81%)
  3. Overdose — 3 reports (14.29%)
  4. Cerebrovascular Disorder — 1 report (4.76%)
  5. Chronic Obstructive Pulmonary Disease — 1 report (4.76%)
  6. Colitis Ulcerative — 1 report (4.76%)
  7. Dizziness — 1 report (4.76%)
  8. Head Discomfort — 1 report (4.76%)
  9. Myocardial Ischaemia — 1 report (4.76%)
  10. Nerve Compression — 1 report (4.76%)

Source database →

Other Smoking Cessation / Addiction Medicine approved in United States

Frequently asked questions

Is nicotine nasal spray approved in United States?

nicotine nasal spray does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for nicotine nasal spray in United States?

Heinrich-Heine University, Duesseldorf is the originator. The local marketing authorisation holder may differ — check the official source linked above.